{"id":12015,"date":"2008-02-02T17:30:00","date_gmt":"2008-02-02T16:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/astrazeneca-in-italia-vendite-in-calo-del-5\/"},"modified":"2008-02-02T17:30:00","modified_gmt":"2008-02-02T16:30:00","slug":"astrazeneca-in-italia-vendite-in-calo-del-5","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/astrazeneca-in-italia-vendite-in-calo-del-5\/","title":{"rendered":"ASTRAZENECA, IN ITALY SALES DOWN BY 5%"},"content":{"rendered":"<p><strong><font size=\"2\"><br \/> Pharmaceutical group Astrazeneca reported 2007 sales of $29.55 billion, up 11% from $26.47 billion a year ago. However, profits fell from $8.54 billion to $7.98 billion. In Italy, sales fell by 5% last year to around 815 million euros. The decline, commented Hans Sijbesma, CEO of the group in Italy, &quot;substantially reflects the difficult situation of the Italian market&quot;.<\/font><\/strong>&nbsp; Free Market of 02\/01\/2008 p. 14&nbsp;&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Il gruppo farmaceutico Astrazeneca ha riportato vendite per il 2007 pari a 29,55 miliardi di dollari, in rialzo dell&#8217;11% rispetto ai 26,47 miliardi di un anno fa. I profitti sono tuttavia calati da 8,54 a 7,98 miliardi di dollari. In Italia le vendite sono scese del 5% l&#8217;anno scorso a circa 815 milioni di euro. &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-12015","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/12015","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=12015"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/12015\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=12015"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=12015"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=12015"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}